Cognitive function in SMA patients with 2 or 3 SMN2 copies treated with SMN-modifying or gene addition therapy during the first year of life
Paula Steffens, Deike Weiss, Anna Perez, Manuel Appel, P. Weber, Claudia Weiß, Corinna Stoltenburg, Ute Ehinger, Maja von der Hagen, Jens Schallner, B Claussen, Ilka Lode, Andreas Hahn, Rahel Schuler, Lena Ruß, Andreas Ziegler, Jonas Denecke, Jessika Johannsen
Topics & Concepts
SMA*Spinal muscular atrophyCognitionMedicineWeaknessGenetic enhancementDiseaseAtrophyGeneMuscle weaknessPhysical medicine and rehabilitationBioinformaticsInternal medicineBiologySurgeryGeneticsPsychiatryMathematicsCombinatoricsNeurogenetic and Muscular Disorders ResearchCardiomyopathy and Myosin StudiesCraniofacial Disorders and Treatments